366 related articles for article (PubMed ID: 17322557)
1. Effects of Toxoplasma gondii infection on the brain.
Carruthers VB; Suzuki Y
Schizophr Bull; 2007 May; 33(3):745-51. PubMed ID: 17322557
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Infection Immunity Regulated by
Hwang YS; Shin JH; Yang JP; Jung BK; Lee SH; Shin EH
Front Immunol; 2018; 9():158. PubMed ID: 29459868
[TBL] [Abstract][Full Text] [Related]
3. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
[TBL] [Abstract][Full Text] [Related]
4. Effects of toxoplasma on human behavior.
Flegr J
Schizophr Bull; 2007 May; 33(3):757-60. PubMed ID: 17218612
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Toxoplasma gondii in the central nervous system: a fine-tuned balance between the parasite, the brain and the immune system.
Blanchard N; Dunay IR; Schlüter D
Parasite Immunol; 2015 Mar; 37(3):150-8. PubMed ID: 25573476
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.
Lüder CG; Giraldo-Velásquez M; Sendtner M; Gross U
Exp Parasitol; 1999 Sep; 93(1):23-32. PubMed ID: 10464035
[TBL] [Abstract][Full Text] [Related]
7. A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.
Hinze-Selch D; Däubener W; Eggert L; Erdag S; Stoltenberg R; Wilms S
Schizophr Bull; 2007 May; 33(3):782-8. PubMed ID: 17387159
[TBL] [Abstract][Full Text] [Related]
8. The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis.
Wilson EH; Hunter CA
Int J Parasitol; 2004 Apr; 34(5):543-8. PubMed ID: 15064118
[TBL] [Abstract][Full Text] [Related]
9. Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.
Sa Q; Ochiai E; Tiwari A; Perkins S; Mullins J; Gehman M; Huckle W; Eyestone WH; Saunders TL; Shelton BJ; Suzuki Y
J Immunol; 2015 Aug; 195(3):796-800. PubMed ID: 26091720
[TBL] [Abstract][Full Text] [Related]
10. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
11. Host resistance in the brain against Toxoplasma gondii.
Suzuki Y
J Infect Dis; 2002 Feb; 185 Suppl 1():S58-65. PubMed ID: 11865441
[TBL] [Abstract][Full Text] [Related]
12. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
[TBL] [Abstract][Full Text] [Related]
13. The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.
Suzuki Y
Parasitol Int; 2020 Jun; 76():102030. PubMed ID: 31778800
[TBL] [Abstract][Full Text] [Related]
14. Early infections of Toxoplasma gondii and the later development of schizophrenia.
Mortensen PB; Nørgaard-Pedersen B; Waltoft BL; Sørensen TL; Hougaard D; Yolken RH
Schizophr Bull; 2007 May; 33(3):741-4. PubMed ID: 17329231
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.
Suzuki Y; Sa Q; Gehman M; Ochiai E
Expert Rev Mol Med; 2011 Oct; 13():e31. PubMed ID: 22005272
[TBL] [Abstract][Full Text] [Related]
16. Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling.
Still KM; Batista SJ; O'Brien CA; Oyesola OO; Früh SP; Webb LM; Smirnov I; Kovacs MA; Cowan MN; Hayes NW; Thompson JA; Tait Wojno ED; Harris TH
PLoS Pathog; 2020 Oct; 16(10):e1009027. PubMed ID: 33108405
[TBL] [Abstract][Full Text] [Related]
17. Growth and development of Toxoplasma gondii in human neurons and astrocytes.
Halonen SK; Lyman WD; Chiu FC
J Neuropathol Exp Neurol; 1996 Nov; 55(11):1150-6. PubMed ID: 8939198
[TBL] [Abstract][Full Text] [Related]
18. Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.
Cekanaviciute E; Dietrich HK; Axtell RC; Williams AM; Egusquiza R; Wai KM; Koshy AA; Buckwalter MS
J Immunol; 2014 Jul; 193(1):139-49. PubMed ID: 24860191
[TBL] [Abstract][Full Text] [Related]
19. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
Prandota J
Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
[TBL] [Abstract][Full Text] [Related]
20. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
